Welcome to LookChem.com Sign In|Join Free

CAS

  • or

38583-85-6

Post Buying Request

38583-85-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

38583-85-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 38583-85-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,8,5,8 and 3 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 38583-85:
(7*3)+(6*8)+(5*5)+(4*8)+(3*3)+(2*8)+(1*5)=156
156 % 10 = 6
So 38583-85-6 is a valid CAS Registry Number.

38583-85-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-chloro-N6-cyclohexyladenosine

1.2 Other means of identification

Product number -
Other names 2-chloro-N6 -cyclohexyladenosine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:38583-85-6 SDS

38583-85-6Relevant articles and documents

METHODS OF PREVENTING, REDUCING OR TREATING MACULAR DEGENERATION

-

Page/Page column 42, (2016/06/28)

The present invention is directed to selective adenosine A1 agonist compounds, pharmaceutical compositions comprising such compounds, and methods of using such compounds to treat, reduce or prevent age-related macular degeneration.

METHOD OF REDUCING INTRAOCULAR PRESSURE IN HUMANS

-

Page/Page column 32; 33, (2010/11/17)

Provided herein are compounds of Formula I, compositions comprising an effective amount of a compound of Formula I, and methods for reducing intraocular pressure comprising administering an effective amount of compounds of Formula I to a subject in need t

Anti-dementia agents

-

, (2008/06/13)

An anti-dementia agent comprising as an active ingredient an adenosine derivative is disclosed. The anti-dementia agent is useful in the therapy of various types of dementia, especially senile dementia. Examples of the adenosine derivative include L-N6 -phenylisopropyl-adenosine, 2-chloroadenosine, N6 -cyclohexyladenosine, adenosine-5'-(N-cyclopropyl)carboxamide.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 38583-85-6